The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Workforce
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Case Report: Diagnosing a Lupus-Flare Mimic

Case Report: Diagnosing a Lupus-Flare Mimic

August 12, 2020 • By Nobuya Abe, MD, Yuichiro Fujieda, MD, PhD, & Tatsuya Atsumi, MD, PhD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

The diagnosis of rheumatic diseases requires the exclusion of other systemic disorders. Infection, hematologic conditions, malignancies and some drugs may all lead to syndromes that closely mimic rheumatic diseases, which may lead to diagnostic delays.

You Might Also Like
  • Case Report: An Adult-Onset Still’s Disease Mimic
  • Rheumatology Case Report: Bullous Lesions in Patient with Lupus
  • Fellow’s Forum Case Report: True Vasculitis or Vasculitis Mimic?
Explore This Issue
August 2020

Idiopathic multicentric Castleman disease (iMCD) is a heterogeneous group of lympho­proliferative diseases (LPDs) characterized by systemic inflammatory manifestations.1,2 As with systemic lupus erythematosus (SLE), patients may present with auto­immune thrombocytopenia, serositis and lupus nephritis. iMCD associated with thrombo­cytopenia, anasarca, myelo­fibrosis, renal dysfunction and organomegaly (iMCD-TAFRO) represents a subset of iMCD.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Distinguishing iMCD-TAFRO from SLE is critical to determine the appropriate treatment. Here we report on a patient with iMCD-TAFRO who presented with symptoms consistent with undifferentiated connective tissue disease (UCTD).

Case Report

A 41-year-old Japanese woman presented with Raynaud’s phenomenon. Laboratory testing revealed that she had anti-nuclear antibodies (ANAs) and anti-U1 ribo­nucleoprotein (RNP) antibodies. A farmer, she had no other symptoms associated with SLE, scleroderma or idiopathic inflammatory myopathy. Her Raynaud’s phenomenon was treated with vasodilators, and she was given a tentative diagnosis of UCTD.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Seven years later, she developed acute abdominal pain. Thickening of the gallbladder wall and gallstones were detected by ultrasound, leading to a diagnosis of acute cholecystitis. Her symptoms did not improve with fasting or antibiotic therapy, and she subsequently gained 10 kg weight in a month, and developed fever, dyspnea and abdominal distention. She was then admitted to our unit.

Laboratory results revealed anemia (hemoglobin 6.8 g/dL; normal range [NR] 11.3–15.2); thrombocytopenia (platelets 3.9×104/µL; NR 13.0×104–36.9×104); low albumin (2.6 g/dL; NR 3.8–5.2); renal dysfunction, requiring renal replacement therapy; and systemic inflammation (C-reactive protein [CRP] 55.6 mg/L; NR <3.0). We found slightly elevated levels of soluble interleukin (IL) 2 receptor (659 U/mL; NR 145–519), IL-6 (25 pg/mL; NR <4.0) and vascular endothelial growth factor (VEGF) (118 pg/L, NR <38.3).

Her complement levels were normal, and tests for autoantibodies, including double-stranded-DNA (dsDNA) antibodies and anti-Ro/La antibodies, were negative. Serolo­gies for hepatitis B, hepatitis C, Epstein-Barr virus, cytomegalovirus, human immunodeficiency virus and human herpesvirus 8 (HHV-8) were negative.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

A urinalysis showed hematuria and proteinuria (urinary protein to creatinine ratio 4.69 g/g·Cr) with active urine sediment, such as granular and waxy casts. Computed tomography revealed bilateral pleural effusions, massive ascites, splenomegaly and generalized lymphadenopathy (see Figure 1, below).

Figure 1: Computed tomography demonstrates bilateral pleural effusion and massive ascites.

Figure 1: Computed tomography demonstrates bilateral pleural effusion and massive ascites.

The patient was initially diagnosed with SLE, based on her serositis, nephritis and pancytopenia in the presence of ANA and anti-U1 RNP antibodies. We treated her with pulse methylprednisolone (1,000 mg/day for three days), followed by prednisolone (1.0 mg/kg/day), mycophenolate mofetil (2,000 mg/day) and tacrolimus (3 mg/day), with transient hemodialysis. However, her condition gradually progressed.

We performed a bone marrow aspiration and biopsy. Although the bone marrow aspiration was dry, the bone marrow biopsy led to the discovery of mild myelofibrosis with an increased number of slightly atypical, multi-nucleated megakaryocytes, consistent with a diagnosis of iMCD-TAFRO.

Despite treatment with intravenous tocilizumab (400 mg) and administration of a thrombopoietin receptor agonist, her symptoms did not improve. However, after administration of cyclosporine A (CsA, 3 mg/kg/day) with a target trough serum CsA level of 150–250 ng/mL, the patient finally achieved full recovery.

Pages: 1 2 3 4 | Single Page

Filed Under: Conditions, SLE (Lupus) Tagged With: Castleman's disease, Raynaud’s phenomenonIssue: August 2020

You Might Also Like:
  • Case Report: An Adult-Onset Still’s Disease Mimic
  • Rheumatology Case Report: Bullous Lesions in Patient with Lupus
  • Fellow’s Forum Case Report: True Vasculitis or Vasculitis Mimic?
  • Systemic Lupus Erythematosus Without Kidney Involvement: A Case Report

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.